The Trump administration struck a new deal with Eli Lilly to offer the drug maker’s weight loss drug to some Medicare recipients.
Lilly recently announced that, starting next year, its GLP-1 weight loss drug, Zepbound, will be offered to many Medicare patients with obesity. They say the deal will open access to millions of adults and address gaps for patients who have limited funds and access to weight loss drugs.
Lilly’s stock fell slightly after the announcement.
First American Nuclear has announced that it will develop an Indiana-based power plant that will initially use natural gas and then shift to a reactor that will run on fuel from nuclear waste.
Expected to open in 2028, the power plant is scheduled to transition from natural gas to liquid metal nuclear fuel around 2032. The 240-megawatt facility will include a system to reprocess and reuse…
